527 related articles for article (PubMed ID: 27011184)
21. MicroRNAs as potential biomarkers in cancer: opportunities and challenges.
Lan H; Lu H; Wang X; Jin H
Biomed Res Int; 2015; 2015():125094. PubMed ID: 25874201
[TBL] [Abstract][Full Text] [Related]
22. MicroRNAs Role in Prostate Cancer.
Balacescu O; Dumitrescu RG; Marian C
Methods Mol Biol; 2018; 1856():103-117. PubMed ID: 30178248
[TBL] [Abstract][Full Text] [Related]
23. Circulating miRNAs in cancer: from detection to therapy.
Wang WT; Chen YQ
J Hematol Oncol; 2014 Dec; 7():86. PubMed ID: 25476853
[TBL] [Abstract][Full Text] [Related]
24. Role of microRNAs in the development, prognosis and therapeutic response of patients with prostate cancer.
Ghafouri-Fard S; Shoorei H; Taheri M
Gene; 2020 Oct; 759():144995. PubMed ID: 32721477
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma.
Schaefer A; Jung M; Mollenkopf HJ; Wagner I; Stephan C; Jentzmik F; Miller K; Lein M; Kristiansen G; Jung K
Int J Cancer; 2010 Mar; 126(5):1166-76. PubMed ID: 19676045
[TBL] [Abstract][Full Text] [Related]
26. Serum microRNAs as powerful cancer biomarkers.
Wittmann J; Jäck HM
Biochim Biophys Acta; 2010 Dec; 1806(2):200-7. PubMed ID: 20637263
[TBL] [Abstract][Full Text] [Related]
27. Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer.
Rachagani S; Macha MA; Heimann N; Seshacharyulu P; Haridas D; Chugh S; Batra SK
Adv Drug Deliv Rev; 2015 Jan; 81():16-33. PubMed ID: 25453266
[TBL] [Abstract][Full Text] [Related]
28. Exploiting Epigenetic Alterations in Prostate Cancer.
Baumgart SJ; Haendler B
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28486411
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA in prostate cancer: Practical aspects.
Patil PA; Magi-Galluzzi C
Histol Histopathol; 2015 Dec; 30(12):1379-96. PubMed ID: 26186079
[TBL] [Abstract][Full Text] [Related]
30. Secretory miRNAs as novel cancer biomarkers.
Zhang J; Zhao H; Gao Y; Zhang W
Biochim Biophys Acta; 2012 Aug; 1826(1):32-43. PubMed ID: 22440944
[TBL] [Abstract][Full Text] [Related]
31. Circulating MicroRNAs as Biomarkers in Biliary Tract Cancers.
Letelier P; Riquelme I; Hernández AH; Guzmán N; Farías JG; Roa JC
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27223281
[TBL] [Abstract][Full Text] [Related]
32. Circulating microRNAs: potential biomarkers for common malignancies.
Khoury S; Tran N
Biomark Med; 2015; 9(2):131-51. PubMed ID: 25689901
[TBL] [Abstract][Full Text] [Related]
33. Emerging role of microRNAs in prostate cancer: implications for personalized medicine.
Gandellini P; Folini M; Zaffaroni N
Discov Med; 2010 Mar; 9(46):212-8. PubMed ID: 20350487
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA Theranostics in Prostate Cancer Precision Medicine.
Matin F; Jeet V; Clements JA; Yousef GM; Batra J
Clin Chem; 2016 Oct; 62(10):1318-33. PubMed ID: 27540032
[TBL] [Abstract][Full Text] [Related]
35. Clinical utilization of serum- or plasma-based miRNAs as early detection biomarkers for pancreatic cancer: A meta-analysis up to now.
Wei L; Yao K; Gan S; Suo Z
Medicine (Baltimore); 2018 Aug; 97(35):e12132. PubMed ID: 30170450
[TBL] [Abstract][Full Text] [Related]
36. Investigating the regulatory role of miRNAs as silent conductors in the management of pathogenesis and therapeutic resistance of pancreatic cancer.
Abulsoud AI; Elshaer SS; Abdelmaksoud NM; Zaki MB; El-Mahdy HA; Ismail A; Al-Noshokaty TM; Fathi D; Abdel-Reheim MA; Mohammed OA; Doghish AS
Pathol Res Pract; 2023 Nov; 251():154855. PubMed ID: 37806169
[TBL] [Abstract][Full Text] [Related]
37. Serum microRNAs as potential noninvasive biomarkers for glioma.
Yu X; Li Z
Tumour Biol; 2016 Feb; 37(2):1407-10. PubMed ID: 26628296
[TBL] [Abstract][Full Text] [Related]
38. MicroRNAs in Neuroblastoma: Biomarkers with Therapeutic Potential.
Galardi A; Colletti M; Businaro P; Quintarelli C; Locatelli F; Di Giannatale A
Curr Med Chem; 2018 Feb; 25(5):584-600. PubMed ID: 28971761
[TBL] [Abstract][Full Text] [Related]
39. Recent progress and perspectives on prostate cancer biomarkers.
Hatakeyama S; Yoneyama T; Tobisawa Y; Ohyama C
Int J Clin Oncol; 2017 Apr; 22(2):214-221. PubMed ID: 27730440
[TBL] [Abstract][Full Text] [Related]
40. Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review.
Huang YK; Yu JC
World J Gastroenterol; 2015 Sep; 21(34):9863-86. PubMed ID: 26379393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]